August 25, 2011 – Transcatheter structural heart occluder maker Occlutech said this week it closed a 15 million Euro ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
August 23, 2011 — A new study shows heart attack patients are now being treated an average of 32 minutes faster than ...
August 23, 2011 — PLC Systems Inc. said the final results from the REMEDIAL II investigator-sponsored clinical trial ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
August 23, 2011 — Cardium Therapeutics received the final $1.1 million payment from Royal Philips Electronics in ...
August 19, 2011 - Neovasc Inc. accomplished $4.7 million in financing to complete the COSIRA clinical trial for the ...
August 18, 2011 — The antiplatelet agent prasugrel (trade name Effient), in combination with aspirin, was associated ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
August 17, 2011 — Our Lady of Lourdes Medical Center performed its first “hybrid” heart surgery and what is believed to ...
August 12, 2011— Simbionix USA Corp., a provider of medical simulation training and education products for medical ...
August 10, 2011 — Hospitals vary markedly when it comes to the rate at which diagnostic coronary angiography or ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
Aug. 2, 2011 — New York University (NYU) Langone Medical Center received an $84 million grant from the National Heart ...
Paramedics in Bellingham, Wash., used the Lucas device on patient Nancy Olson, who went into cardiac arrest following a ...
July 29, 2011 — The U.S. Food and Drug Administration (FDA) this week issued draft guidance that clarifies when changes ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
July 26, 2011 — Concentric Medical Inc. has launched the DAC 070 Catheter, the fourth and largest diameter addition to ...
July 21, 2011 – The U.S. Food and Drug Administration (FDA) today approved AstraZeneca’s blood-thinning drug ticagrelor ...
Coronary revascularization does not always lead to coronary reperfusion. When readily available, percutaneous coronary ...
August 25, 2011